GtoPdb Ligand ID: 7485

Synonyms: B2036-PEG | Somavert®
pegvisomant is an approved drug (FDA (2003), EMA (2008))
Comment: Pegvisomant is a PEGylated 191 amino acid protein analogue of growth hormone, with antagonist action at the growth hormone receptor. The peptide sequence can be obtained via the ChEMBL link. PEGylation protects the peptide from proteolytic breakdown and extends its bioactive half-life.
Compound class Peptide or derivative
Approved drug? Yes (FDA (2003), EMA (2008))
International Nonproprietary Names
INN number INN
7941 pegvisomant
B2036-PEG | Somavert®
Database Links
ChEMBL Ligand CHEMBL1201515
DrugBank Ligand DB00082
GtoPdb PubChem SID 187051788
Search PubMed clinical trials pegvisomant
Search PubMed titles pegvisomant
Search PubMed titles/abstracts pegvisomant
Wikipedia Pegvisomant